Status:
COMPLETED
Short Stature Related Distress
Lead Sponsor:
Rabin Medical Center
Collaborating Sponsors:
Pfizer
Conditions:
Idiopathic Short Stature
Self Image
Eligibility:
MALE
8-17 years
Phase:
PHASE4
Brief Summary
The research aims to provide data on gender-related psychological impact of GH (Growth Hormone)treatment. Implicit measurable psychological metrics of the therapy outcome on males are to be evaluated ...
Detailed Description
Study Design: A prospective randomized, double blind, placebo controlled trial design, comparing four research groups, with 4 repeated psychological measures (before treatment, after 3 months,after 1...
Eligibility Criteria
Inclusion
- 1 Segment 1 :Boys at the age range of 8-13 years 2. Segment 2: Boys at the age range of 12-17 years 3. Tanner stage 1 (segment 1 only) 4. more than 2 SD's (standard deviation) below the average height
Exclusion
- Mental retardation,
- Psychiatric illness,
- Lack of informed consent\\assent.
- Health status that required chronic treatment with steroids
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01246219
Start Date
October 1 2011
End Date
November 1 2017
Last Update
December 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schneider Children's Medical center
Petah Tikva, Israel, 49202